CAN Stock Overview
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets.
Cann Group Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.26|
|52 Week High||AU$0.43|
|52 Week Low||AU$0.23|
|1 Month Change||-5.46%|
|3 Month Change||-13.33%|
|1 Year Change||-10.35%|
|3 Year Change||-81.09%|
|5 Year Change||-78.33%|
|Change since IPO||-59.69%|
Recent News & Updates
|CAN||AU Pharmaceuticals||AU Market|
Return vs Industry: CAN exceeded the Australian Pharmaceuticals industry which returned -22.5% over the past year.
Return vs Market: CAN underperformed the Australian Market which returned -7.1% over the past year.
|CAN Average Weekly Movement||5.8%|
|Pharmaceuticals Industry Average Movement||10.2%|
|Market Average Movement||9.3%|
|10% most volatile stocks in AU Market||16.3%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: CAN is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CAN's weekly volatility (6%) has been stable over the past year.
About the Company
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Bundoora, Australia.
Cann Group Limited Fundamentals Summary
|CAN fundamental statistics|
Is CAN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CAN income statement (TTM)|
|Cost of Revenue||AU$0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.075|
|Net Profit Margin||-235.52%|
How did CAN perform over the long term?See historical performance and comparison